You just read:

Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension

News provided by

Novartis Pharmaceuticals Corporation

Sep 25, 2011, 07:03 ET